Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cash for tests: study tests whether money boosts HIV screening in vulnerable women

NCT ID NCT03768986

Prevention Sponsor: UConn Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether offering a $25 to $40 incentive would encourage more African American, Latina, and low-income women to get tested for HIV. Over 300 women were randomly assigned to receive either standard referral and education or the same plus a monetary reward for testing. The goal was to see if the incentive increased testing rates and repeat testing over a year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
monetary incentive for HIV testing
What this could lead to
If effective, this approach could be widely adopted by community organizations to increase HIV testing and early diagnosis among high-risk women.
What could go wrong
This is a completed behavioral study, not a drug trial. The incentive may not lead to sustained testing behavior, and results may not apply to all communities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

334 people

The number who actually took part.

Started

Feb 2019

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Clinician Participants: * \>6 months experience as a case manager, medical/nursing clinician or mental health/substance use therapist * currently work with women at high risk for contracting HIV * able to attend a training and participate in the evaluative components * willing to conduct both standard HIV referral for testing and orientation to an online training and the same with reinforcement, depending on client's random assignment. Exclusion Criteria for Clinician Participants \- planning to end employment at the agency within the next 3 months Inclusion Criteria for Client Participants: * female * identifies as African American/black or Latina/Hispanic OR is living in poverty based on the most recent year's federal poverty guidelines * 18 and older * one or more high risk factors for HIV: intravenous drug use; or sexually active with past year partners with HIV or of unknown HIV status and no or inconsistent use of condoms * English or Spanish speaking * passes a quiz related to understanding the informed consent form * has an address at which they expect to be able to receive mail and/or a phone to retrieve messages for the next 15 months Exclusion Criteria for Client Participants: * received a fourth-generation HIV test in the past 6 months * HIV positive.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Contingency management are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contingency management HIV HIV testing Women

Contacts and locations

Locations

  • UConn Health

    Farmington, Connecticut, 06030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.